featured
Assessment of Hyperprogressive Disease During Cancer Treatment With Immune Checkpoint Inhibitors
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Network Open
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Definition, Incidence, and Challenges for Assessment of Hyperprogressive Disease During Cancer Treatment With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
JAMA Netw Open 2021 Mar 01;4(3)e211136, HJ Park, KW Kim, SE Won, S Yoon, YK Chae, SH Tirumani, NH RamaiyaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.